AIM ImmunoTech
AIM
#11055
Rank
A$6.91 M
Marketcap
A$0.17
Share price
-4.50%
Change (1 day)
-91.84%
Change (1 year)

Earnings for AIM ImmunoTech (AIM)

Earnings in 2026 (TTM): -A$19.82 Million

According to AIM ImmunoTech 's latest financial reports the company's current earnings are A$0.09 Million. In 2025 the company made an earning of -A$21.09 Million, an increase over its 2024 earnings that were of -A$26.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AIM ImmunoTech from 1995 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$19.82 Million-6.03%
2025 -A$21.09 Million-19.41%
2024 -A$26.17 Million-40.2%
2023 -A$43.76 Million48.94%
2022 -A$29.38 Million1.66%
2021 -A$28.9 Million32.66%
2020 -A$21.79 Million51.18%
2019 -A$14.41 Million-2.81%
2018 -A$14.83 Million18.82%
2017 -A$12.48 Million10.09%
2016 -A$11.34 Million-50.74%
2015 -A$23.01 Million-12.72%
2014 -A$26.37 Million7.55%
2013 -A$24.52 Million-6.51%
2012 -A$26.22 Million21.22%
2011 -A$21.63 Million-7.56%
2010 -A$23.4 Million16.76%
2009 -A$20.04 Million3.54%
2008 -A$19.36 Million-33.58%
2007 -A$29.15 Million3.18%
2006 -A$28.25 Million89.3%
2005 -A$14.93 Million-9.31%
2004 -A$16.46 Million50.17%
2003 -A$10.96 Million9.55%
2002 -A$10.01 Million-24.79%
2001 -A$13.3 Million-2.66%
2000 -A$13.67 Million-6.78%
1999 -A$14.66 Million40.58%
1998 -A$10.43 Million6.15%
1997 -A$9.83 Million41.3%
1996 -A$6.95 Million360%
1995 -A$1.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion 1,098.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million 36.76%๐Ÿ‡บ๐Ÿ‡ธ USA